Furthermore, it was shown that vaccinating rats with isogenic tumor cells (MCA205 fibrosarcoma cell line) treated with nsPEF (50 kV, 100 ns, 500 pulses) stimulates an immune response that inhibits the growth of secondary tumors in a CD8+-dependent manner [231]. The gene discussed is CD8A; the disease is neoplasm.